Double agents and breakdown of integrity at the neuromuscular junction in Miller-Fisher syndrome.
Slater
C
C
D000109:Acetylcholine / Q000378:metabolism; D001323:Autoantibodies / Q000009:adverse effects / Q000276:immunology*; D005732:Gangliosides / Q000276:immunology; D006801:Humans; D019846:Miller Fisher Syndrome / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D009469:Neuromuscular Junction / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D009435:Synaptic Transmission / Q000276:immunology
D001323:Autoantibodies; D005732:Gangliosides; C039129:GQ1b ganglioside; D000109:Acetylcholine